PL2591798T3 - Szczepionka do zastosowania w immunoterapii nowotworów - Google Patents
Szczepionka do zastosowania w immunoterapii nowotworówInfo
- Publication number
- PL2591798T3 PL2591798T3 PL11188494T PL11188494T PL2591798T3 PL 2591798 T3 PL2591798 T3 PL 2591798T3 PL 11188494 T PL11188494 T PL 11188494T PL 11188494 T PL11188494 T PL 11188494T PL 2591798 T3 PL2591798 T3 PL 2591798T3
- Authority
- PL
- Poland
- Prior art keywords
- vaccine
- tumor immunotherapy
- immunotherapy
- tumor
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 238000009169 immunotherapy Methods 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464499—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4648—Bacterial antigens
- A61K39/464831—Escherichia; Klebsiella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11188494.6A EP2591798B1 (en) | 2011-11-09 | 2011-11-09 | Vaccine for use in tumor immunotherapy |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2591798T3 true PL2591798T3 (pl) | 2015-04-30 |
Family
ID=44992693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL11188494T PL2591798T3 (pl) | 2011-11-09 | 2011-11-09 | Szczepionka do zastosowania w immunoterapii nowotworów |
Country Status (9)
Country | Link |
---|---|
US (1) | US9790260B2 (pl) |
EP (2) | EP2591798B1 (pl) |
JP (1) | JP6029677B2 (pl) |
CN (1) | CN104066443A (pl) |
AU (1) | AU2012334095B2 (pl) |
ES (1) | ES2525205T3 (pl) |
HK (1) | HK1202070A1 (pl) |
PL (1) | PL2591798T3 (pl) |
WO (1) | WO2013068406A1 (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107109365A (zh) * | 2014-07-17 | 2017-08-29 | 布莱恩·J·赫尔尼奇 | 多剂量注射用树突状细胞疫苗的制备及用于阻断her2和her3的联合治疗 |
US20160129097A1 (en) * | 2014-11-06 | 2016-05-12 | Jeremy Delk | Method of processing a veterinary tumor vaccine and a veterinary tumor vaccine processing kit |
CN104606665A (zh) * | 2015-02-13 | 2015-05-13 | 闫书印 | 一种基于骨髓穿刺术的用于骨转移疼痛的治疗配方 |
CN105126094A (zh) * | 2015-08-13 | 2015-12-09 | 安徽农业大学 | 一种拟态弧菌菌影疫苗及其制备方法和应用 |
EP3195878A1 (en) | 2016-01-22 | 2017-07-26 | Werner Lubitz | Bacterial ghosts for the treatment of cancer |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4117125A (en) | 1977-06-24 | 1978-09-26 | Smithkline Corporation | 7-Acylamino-3-[1-[2-(carboxymethylamino]ethyl) tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids |
DE19732829A1 (de) | 1997-07-30 | 1999-02-04 | Lubitz Werner Prof Dr | Sekretion von trägergebundenen Proteinen in das Periplasma und in den extrazellulären Raum |
DE19909770A1 (de) | 1999-03-05 | 2000-09-07 | Werner Lubitz | Bakterienghosts als Träger- und Targetingvehikel |
DE10003241A1 (de) | 2000-01-26 | 2001-08-02 | Werner Lubitz | Verschließen von Bakterienghosts |
US7037500B1 (en) * | 2000-09-08 | 2006-05-02 | The Trustees Of Columbia University In The City Of New York | Method for using phagocytic particles and ATP receptors to deliver antigens to MHC class I receptors to induce immunity against microbial pathogens or tumors or to suppress immunity |
AU2002328340B2 (en) | 2001-07-11 | 2007-06-28 | Werner Lubitz | Nucleic acid free ghost preparations |
BR0316758A (pt) * | 2002-12-16 | 2005-10-25 | Globeimmune Inc | Vacinas baseadas em levedura como imunoterapia |
ES2401706T3 (es) | 2005-07-27 | 2013-04-23 | Eli Lilly And Company | Un método de tratar células cancerosas para crear una célula cancerosa modificada que provoca una respuesta inmunogénica |
US20110172826A1 (en) * | 2005-12-14 | 2011-07-14 | Amodei Dario G | Device including altered microorganisms, and methods and systems of use |
US7736642B2 (en) | 2006-02-02 | 2010-06-15 | Globeimmune, Inc. | Yeast-based vaccine for inducing an immune response |
US20080031900A1 (en) | 2006-06-30 | 2008-02-07 | Baylor Research Institute | Dendritic Cells Generated Using GM-CSF and Interferon Alpha and Loaded with Heat-Treated and Killed Cancer Cells |
EP1897557A1 (en) * | 2006-09-07 | 2008-03-12 | Helmholtz-Zentrum für Infektionsforschung GmbH | Use of glycolipids as adjuvants |
PT2240570E (pt) | 2008-01-18 | 2014-02-17 | Werner Lubitz | Processo de produção de fantasmas bacterianos (bg) utilizando betapropiolactona (blp) para inactivação final |
MX2011010977A (es) | 2009-04-17 | 2012-02-29 | Us Health | Composiciones inmunoterapeuticas combinadas contra cancer y metodos. |
-
2011
- 2011-11-09 PL PL11188494T patent/PL2591798T3/pl unknown
- 2011-11-09 EP EP11188494.6A patent/EP2591798B1/en active Active
- 2011-11-09 ES ES11188494.6T patent/ES2525205T3/es active Active
-
2012
- 2012-10-31 US US13/665,145 patent/US9790260B2/en active Active
- 2012-11-07 CN CN201280055046.2A patent/CN104066443A/zh active Pending
- 2012-11-07 AU AU2012334095A patent/AU2012334095B2/en not_active Ceased
- 2012-11-07 WO PCT/EP2012/072040 patent/WO2013068406A1/en active Application Filing
- 2012-11-07 JP JP2014540437A patent/JP6029677B2/ja active Active
- 2012-11-07 EP EP12781120.6A patent/EP2776060A1/en not_active Withdrawn
-
2015
- 2015-03-16 HK HK15102670.6A patent/HK1202070A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN104066443A (zh) | 2014-09-24 |
US20130115245A1 (en) | 2013-05-09 |
HK1202070A1 (en) | 2015-09-18 |
EP2591798B1 (en) | 2014-11-19 |
US9790260B2 (en) | 2017-10-17 |
EP2776060A1 (en) | 2014-09-17 |
NZ624069A (en) | 2015-10-30 |
JP6029677B2 (ja) | 2016-11-24 |
AU2012334095B2 (en) | 2017-10-12 |
ES2525205T3 (es) | 2014-12-18 |
AU2012334095A1 (en) | 2014-05-29 |
JP2015504423A (ja) | 2015-02-12 |
WO2013068406A1 (en) | 2013-05-16 |
EP2591798A1 (en) | 2013-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2714073A4 (en) | ANTI-CANCER ANTIGEN GENE VACCINE IN SITU | |
HK1197182A1 (en) | Cancer immunotherapy | |
LT3892295T (lt) | Individualizuotos vakcinos nuo vėžio | |
EP2752198A4 (en) | PREPARATION OF VACCINE FOR THE TREATMENT OF CANCER | |
IL231043A0 (en) | vaccine | |
SI2780332T1 (sl) | Morfolinilbenzotriazini za uporabo pri terapiji raka | |
GB201120860D0 (en) | Cancer immunotherapy | |
GB201119999D0 (en) | Vaccine | |
HK1201176A1 (en) | Antigen presenting cancer vaccine | |
HK1202070A1 (en) | Vaccine for tumor immunotherapy | |
EP2763699A4 (en) | VACCINE | |
EP2771453A4 (en) | DIATOM-BASED VACCINES | |
ZA201402071B (en) | Vaccine therapy | |
PL2714071T3 (pl) | Zindywidualizowane szczepionki przeciwrakowe | |
GB201120000D0 (en) | Vaccine | |
GB201107549D0 (en) | Cancer vaccine | |
GB201108982D0 (en) | Vaccines | |
GB201108986D0 (en) | Vaccines | |
GB201108984D0 (en) | Vaccines | |
GB201121647D0 (en) | Vaccine | |
GB201108256D0 (en) | Vaccine |